Bladder Cancer, Biomarkers

Oncology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Element Biosciences
Element BiosciencesCA - San Diego
1 program
Collection of urine and bladder tumor specimensN/A1 trial
Active Trials
NCT02745301CompletedEst. Jan 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Element BiosciencesCollection of urine and bladder tumor specimens

Clinical Trials (1)

NCT02745301Element BiosciencesCollection of urine and bladder tumor specimens

Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder

Start: Apr 2016Est. completion: Jan 2018
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space